New developments in the treatment of pediatric allergic rhinitis and conjunctivitis

Area of Science:

• Pediatrics
• Allergy and Immunology
• Primary Care Medicine

Background:

• Allergic rhinitis affects a quarter of US children, with increasing self-management trends.
• High-deductible insurance and OTC medications influence treatment choices.
• Vitamin D deficiency is a potential factor in allergic diseases, under investigation.

Purpose of the Study:

• To review the role of primary care physicians in managing childhood allergic rhinitis.
• To discuss current treatment strategies, including medication selection and adverse effects.
• To explore emerging therapies like vitamin D supplementation and sublingual immunotherapy.

Main Methods:

• Literature review of current pediatric allergic rhinitis management.
• Discussion of self-management trends and over-the-counter medication use.
• Analysis of emerging research on vitamin D and immunotherapy.

Main Results:

• Primary care physicians are crucial for guiding allergic rhinitis treatment.
• Sublingual immunotherapy is a new FDA-approved option for specific allergens.
• The role of vitamin D in allergic rhinitis requires further research.

Conclusions:

• Primary care physicians play a vital role in optimizing allergic rhinitis care for children.
• New immunotherapy options offer alternatives to traditional allergy shots.
• Further investigation into vitamin D's role may provide novel treatment avenues.